The choice of biological agents or traditional medicines for people with direct spina syndrome requires a combination of factors.
In terms of the severity of the condition,
– Priority of traditional medicines: if the patient is at an early stage of the disease and the condition is relatively light, it can be seen only in occasional pains on the back, in the morning, and the symptoms can be mitigated by appropriate rest, simple non-inflammatory drugs (e.g., Brovent, alchlorphenate, etc.), then the traditional medicine can be tried first. Such drugs reduce inflammation and pain, while maintaining a regular exercise and good physical fitness, among other things, may better control the development of the disease.
– Consideration of biological agents: However, when the condition progresses to a moderate degree, such as a sustained acute back pain, severe restriction of activity, or even when the spinal column has begun to undergo a significant straight, deformative change, or is burdened with other complications such as iris, iris, etc., when the use of biological agents is often more advantageous, it can more effectively contain the inflammatory response of the disease, prevent further deterioration of the condition, and improve the function and physical state of the joint.
Analysis of the effects of treatment
– The limitations of traditional medicines: traditional rheumatological drugs, such as nitrous sulfur, while having some effect on some patients, are generally relatively slow and, after a long period of time, they may not improve as much as they are expected.
– Biological agent advantage: Biological agents tend to function more quickly, with precision in the disruption of key inflammation factors in the mechanism for the outbreak of direct spinal disease, with many patients feeling reduced pain and increased joint activity in a relatively short period of time after use, which can help to increase the patient ‘ s therapeutic confidence and dependence.
Security and tolerance considerations
– Negative effects of traditional medicines: there are some side effects, such as chronic use of inflammatory anti-inflammatory drugs, which may cause gastrointestinal discomfort, damage to liver and kidney function, etc., while some anti-generic drugs may also have adverse effects on the blood system, the reproductive system, etc., and some patients may suffer from insufferability affecting the continuation of treatment.
– Characteristics of biological agents: Although they are generally safe, they are also at risk of infection, allergies, etc., although, in relative terms, biological agents may be a more appropriate option if the patient ‘ s adverse response to traditional medicines is poor, provided that the associated risks are monitored during their use.
From an economic point of view
– Costs of traditional medicines: traditional medicines are mostly relatively pro-people-friendly, health insurance reimbursement rates are generally considerable, long-term use is relatively less economically burdensome and is an important consideration for patients with limited financial means.
– The costs of biological agents are often higher, even if they are partially covered by health insurance reimbursement, they may still have to pay for themselves, and for some families with financial difficulties, there may be concerns about choice, and the advantages of treatment, if economic conditions permit, are indeed worth considering.
In any case, the choice of biological agents or traditional medicines by persons with direct spina syndrome is carefully determined by a doctor ‘ s professional assessment, taking into account his or her own condition, the effects of treatment, tolerance and financial circumstances.
